UPC_APP_546231/2023

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Procedural & sub-applicationsOther ProceduralMunich CDGenericWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

Name not displayed for GDPR reasons. Represented by Oswin RIDDERBUSCH

Respondents

Sanofi-Aventis Deutschland GmbH(Sanofi Group)(Amgen Group)
Amgen Inc.(Sanofi Group)(Amgen Group)

Judges

Ulrike Voß
Andras Kupecz
Casper Struve

Patents

EP3666797

CPC codes: C07K2317/14, C07K2317/34, A61K39/395, A61K2039/505, A61K31/366, A61P3/06, A61K31/66, A61K31/22, A61P9/00, A61P7/00, A61P25/28, A61K2300/00…

Sector: Biotechnology

Outcome

—

Filed: Jul 11, 2023

First decided: —

Language: English

Open on UPC Registry